5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide

C28H26N6O2 — CID 163385201

IUPAC5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide
SMILESCn1cc2cc(-n3nc4c(C(N)=O)cn(CC5CC5)c4c(-c4ccc(C5CC5)cc4)c3=O)ccc2n1
InChIInChI=1S/C28H26N6O2/c1-32-14-20-12-21(10-11-23(20)30-32)34-28(36)24(19-8-6-18(7-9-19)17-4-5-17)26-25(31-34)22(27(29)35)15-33(26)13-16-2-3-16/h6-12,14-17H,2-5,13H2,1H3,(H2,29,35)
InChIKeyFTVMGSSJYOFDIW-UHFFFAOYSA-N
MW478.56 g/mol
LogP4.13
Rot. Bonds6

About 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide

5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide (PubChem CID 163385201) has the molecular formula C28H26N6O2 and a molecular weight of 478.56 g/mol. Its IUPAC name is 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide.

Molecular Properties

Compound Name5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide
PubChem CID163385201
Molecular FormulaC28H26N6O2
Molecular Weight478.56 g/mol
Exact Mass478.21
IUPAC Name5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide
SMILESCn1cc2cc(-n3nc4c(C(N)=O)cn(CC5CC5)c4c(-c4ccc(C5CC5)cc4)c3=O)ccc2n1
InChIInChI=1S/C28H26N6O2/c1-32-14-20-12-21(10-11-23(20)30-32)34-28(36)24(19-8-6-18(7-9-19)17-4-5-17)26-25(31-34)22(27(29)35)15-33(26)13-16-2-3-16/h6-12,14-17H,2-5,13H2,1H3,(H2,29,35)
InChIKeyFTVMGSSJYOFDIW-UHFFFAOYSA-N
XLogP4.13
TPSA100.73 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500478.56
LogP ≤ 54.13
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide?
The IUPAC name of 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide (CID 163385201) is 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide.
What is the SMILES notation for 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide?
The canonical SMILES for 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide is Cn1cc2cc(-n3nc4c(C(N)=O)cn(CC5CC5)c4c(-c4ccc(C5CC5)cc4)c3=O)ccc2n1.
What is the InChIKey of 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide?
The InChIKey is FTVMGSSJYOFDIW-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H26N6O2/c1-32-14-20-12-21(10-11-23(20)30-32)34-28(36)24(19-8-6-18(7-9-19)17-4-5-17)26-25(31-34)22(27(29)35)15-33(26)13-16-2-3-16/h6-12,14-17H,2-5,13H2,1H3,(H2,29,35).
What are the key properties of 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide?
5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide has a molecular weight of 478.56 g/mol, XLogP of 4.13, 6 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(cyclopropylmethyl)-4-(4-cyclopropylphenyl)-2-(2-methylindazol-5-yl)-3-oxopyrrolo[3,2-c]pyridazine-7-carboxamide is sourced from PubChem (CID 163385201), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).